Healthtech Startups
16,708 companies tagged Healthtech, with their investors and founders.
Aptimmune develops vaccines for swine health, partnering with vaccine development and swine health consulting companies to speed product development, testing and manufacturing. It serves the swine veterinary and animal health industry.
3 investors
Arbutus Medical develops FDA-cleared surgical devices for orthopedic trauma procedures, including innovative drill technology and sterile-packed procedure kits designed for use in low-resource hospitals globally.
3 investors
AreCor develops proprietary pharmaceutical products for diabetes, obesity, and cardiometabolic diseases using its Arestat technology platform. The company targets areas of high unmet patient need in high-value therapeutic markets.
3 investors
The company develops therapies for people with severe autoimmune diseases.
3 investors
Arialys Therapeutics develops precision medicines designed to block pathogenic autoantibodies that target brain receptors such as the NMDA receptor, aiming to treat neuropsychiatric disorders driven by autoimmune disease. It focuses on autoimmune neuropsychiatry, addressing conditions including encephalitis, schizophrenia, dementia, and cancer-related cognitive impairment.
3 investors
Arrae creates natural, science-backed wellness supplements for women that address everyday health concerns like bloating, sleep, and weight management. The company sells directly to consumers and through retail partnerships including Target, Ulta, and Sprouts.
3 investors
Arrive Health provides in-workflow software that gives clinical care teams real-time insurance, medication cost, and coverage data plus automation for prior authorization and patient outreach. The tools aim to improve medication affordability, time to therapy, and adherence while reducing phone calls and faxes.
3 investors
Artera develops AI-powered diagnostic tests that analyze patient biopsy images to predict therapeutic response in cancer care. The company enables personalized treatment decisions and shared decision-making between clinicians and patients, beginning with localized prostate cancer.
3 investors
Arterys provides AI clinical applications for medical imaging that integrate directly into existing PACS and EHR systems to assist physicians with diagnosis and treatment decisions. The platform is cloud-based and designed for radiology workflows in healthcare settings.
3 investors
Artisight builds an AI platform that uses computer vision and operational intelligence to improve hospital workflows and clinician efficiency. The platform connects to existing hospital systems and cameras to help healthcare organizations optimize operational performance, quality metrics, and workforce sustainability.
3 investors
Aruna Bio develops a proprietary neural exosome platform and a lead therapeutic neural cell-derived exosome, AB126, designed to cross the blood-brain barrier. The company targets acute neurological conditions and chronic neurodegenerative diseases through mechanisms that reduce neuro-inflammation and promote neuro-protection and neuro-regeneration.
3 investors
Asgard Therapeutics develops direct cell reprogramming technologies that convert cancer cells into dendritic cells to restore anti-cancer immune responses. The company focuses on oncology immunotherapy through its TrojanDC approach.
3 investors
Ash provides an end-to-end platform for at-home and in-person health testing, connecting organizations to a network of CLIA-/CAP-certified labs and licensed providers through a single integration. It offers white-label test kits, patient support and engagement, provider-of-record handling, patient portals, and program reporting for organizations running branded health testing programs across the US.
3 investors
Asimily provides an exposure management platform that inventories, prioritizes, and mitigates cybersecurity risk across IoMT, IoT, IT, and OT devices. It offers device visibility, MITRE ATT&CK-based vulnerability analysis, network segmentation orchestration, patching, and threat detection to help organizations meet compliance requirements such as HIPAA, FDA, and NIST.
3 investors
Aspero Medical develops the Pillar balloon overtube solution with micro-textured design to improve control and anchoring during balloon endoscopy for small bowel diagnosis and treatment. The technology reduces procedure time and sedation requirements for gastrointestinal interventions.
3 investors
Assuric offers an AI-based compliance platform built for the healthtech sector. It replaces spreadsheet-driven, manual processes so digital health and AI companies can meet regulatory requirements more quickly and get products deployed sooner.
3 investors
Astek Diagnostics develops a diagnostic platform for rapid and accurate detection of urinary tract infections and related conditions in clinical specimens. The company serves physicians and patients needing point-of-care diagnostic solutions for infectious diseases.
3 investors
Aster provides patient management software and agentic AI voice tools for healthcare providers. The company was acquired by Elation.
3 investors
AtaiBeckley develops rapid-acting mental health treatments for patients with difficult-to-treat conditions through rigorous scientific research and clinical applications. The company was formed from the strategic combination of atai Life Sciences and Beckley Psytech.
3 investors
ATB Therapeutics develops bifunctional antibodies (atbodies) that combine multiple targeting and killing domains to treat hematological malignancies, solid tumors, and autoimmune diseases. The company aims to create therapeutics with increased potency, stability, and targeted exposure for patients worldwide.
3 investors
3 investors
A wearable device company developing brain-sensing technology using nanotechnology for consumer use.
3 investors
Attralus develops pan-amyloid removal (PAR) therapeutics — biologics and imaging agents designed to bind and remove toxic amyloid — to treat patients with systemic amyloidosis across all disease types and stages. The company operates in the biotech and drug development space targeting these progressive, often fatal diseases.
3 investors
aTyr is a clinical-stage biotechnology company developing therapies derived from tRNA synthetase biology to treat fibrosis and inflammation, with its lead candidate efzofitimod in clinical trials for interstitial lung disease. The company leverages a proprietary discovery platform targeting immune-mediated disorders in pulmonary and systemic conditions.
3 investors